Reciprocal signaling between translational control pathways and synaptic proteins in autism spectrum disorders
Open accessThe DOI matches its Crossref record; 169 of the 170 references it cites were found in a registry or an index.
Abstract
Pathways regulating translation and synaptic function may be interconnected in autism spectrum disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This hypothesis has been further elaborated by Santini and Klann and others, with new evidence supporting the crucial role of cap-dependent translation protein EIF4E79, 88, 100, 101 in ASD pathophysiology.77”
From Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder (2018) · cites this paper as [79]
In the citing paper
“These syndromes are caused by mutations in single genes (fragile X mental retardation protein 1 (FMR1), methyl-CpG-binding protein 2 (MECP2), TSC1 or TSC2, neurofibromin 1 (NF1) and PTEN, respectively) and account for 5–7% of ASD cases20–22.”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [20]
In the citing paper
“Exaggerated cap-dependent translation is a well-known molecular mechanism regulating neurogenesis77 and contributing to synaptic and behavioral phenotypes associated with ASD and related neurodevelopmental disorders.78, 79”
From Maternal immune activation dysregulation of the fetal brain transcriptome and relevance to the pathophysiology of autism spectrum disorder (2018) · cites this paper as [79]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,914
Verkerk, A. J. M. H., Pieretti, M., Sutcliffe, J. S., Fu, Y.-H., Kuhl, D. P. A., Pizzuti, A., Reiner, O., Richards, S., Victoria, M. F., Zhang, F., et al. (1991) · Cell · doi:10.1016/0092-8674(91)90397-h · Cited by 3,481 · cited 15×
“FMRP is an RNA-binding protein that is involved in many aspects of the posttranscriptional regulation of mRNA, such as stability, dendritic transport, and translational control.”
BackgroundInfluentialMcDonald-McGinn, D. M., Sullivan, K. E., Marino, B., Philip, N., Swillen, A., Vorstman, J. A. S., Zackai, E. H., Emanuel, B. S., Vermeesch, J. R., Morrow, B. E., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.71 · Cited by 2,236
eIF4 Initiation Factors: Effectors of mRNA Recruitment to Ribosomes and Regulators of Translation
Gingras, A.-C., Raught, B., & Sonenberg, N. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.913 · Cited by 2,121 · cited 1×
“eIF4E binds to the cap structure at the 5′ terminus of mRNA and regulates the initiation step of cap-dependent translation (48, 49).”
BackgroundFMRP Stalls Ribosomal Translocation on mRNAs Linked to Synaptic Function and Autism
Darnell, J. C., Van Driesche, S. J., Zhang, C., Hung, K. Y. S., Mele, A., Fraser, C. E., Stone, E. F., Chen, C., Fak, J. J., Chi, S. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.013 · Cited by 2,072
Functional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013
Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
Inoki, K., Li, Y., Xu, T., & Guan, K.-L. (2003) · Genes & Development · doi:10.1101/gad.1110003 · Cited by 1,911
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
Study, P. A. R. I. S., Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1136 · Cited by 1,851
Neuroligins and neurexins link synaptic function to cognitive disease
Südhof, T. C. (2008) · Nature · doi:10.1038/nature07456 · Cited by 1,849
Structural Variation of Chromosomes in Autism Spectrum Disorder
Marshall, C. R., Noor, A., Vincent, J. B., Lionel, A. C., Feuk, L., Skaug, J., Shago, M., Moessner, R., Pinto, D., Ren, Y., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.12.009 · Cited by 1,815
Durand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602
Shank3 mutant mice display autistic-like behaviours and striatal dysfunction
Peça, J., Feliciano, C., Ting, J. T., Wang, W., Wells, M. F., Venkatraman, T. N., Lascola, C. D., Fu, Z., & Feng, G. (2011) · Nature · doi:10.1038/nature09965 · Cited by 1,570
Epidemiological Surveys of Autism and Other Pervasive Developmental Disorders: An Update
Fombonne, E. (2003) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1025054610557 · Cited by 1,505 · cited 13×
“Moreover, several mRNA targets of FMRP encode repressors of the mTORC1 signaling pathway, including tuberin (TSC2) and phosphatase and tensin homolog (PTEN) (34).”
BackgroundInfluentialAbsence of expression of the FMR-1 gene in fragile X syndrome
Pieretti, M., Zhang, F., Fu, Y.-H., Warren, S. T., Oostra, B. A., Caskey, C. T., & Nelson, D. L. (1991) · Cell · doi:10.1016/0092-8674(91)90125-i · Cited by 1,476 · cited 15×
“FMRP is an RNA-binding protein that is involved in many aspects of the posttranscriptional regulation of mRNA, such as stability, dendritic transport, and translational control.”
BackgroundInfluentialRecurrence Risk for Autism Spectrum Disorders: A Baby Siblings Research Consortium Study
Ozonoff, S., Young, G. S., Carter, A., Messinger, D., Yirmiya, N., Zwaigenbaum, L., Bryson, S., Carver, L. J., Constantino, J. N., Dobkins, K., et al. (2011) · Pediatrics · doi:10.1542/peds.2010-2825 · Cited by 1,429
Mapping autism risk loci using genetic linkage and chromosomal rearrangements
The Autism Genome Project Consortium (2007) · Nature Genetics · doi:10.1038/ng1985 · Cited by 1,402
Altered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349 · cited 1×
“Fmr1 null mice exhibit enhanced mGluR-dependent synaptic plasticity (39), increased density of dendritic spines, and numerous filopodia-like spines in the cortex, recapitulating a pathological feature observed in FXS patients (21, 40–42).”
BackgroundNeuroligin Expressed in Nonneuronal Cells Triggers Presynaptic Development in Contacting Axons
Scheiffele, P., Fan, J., Choih, J., Fetter, R., & Serafini, T. (2000) · Cell · doi:10.1016/s0092-8674(00)80877-6 · Cited by 1,218
Coupling of mGluR/Homer and PSD-95 Complexes by the Shank Family of Postsynaptic Density Proteins
Tu, J. C., Xiao, B., Naisbitt, S., Yuan, J. P., Petralia, R. S., Brakeman, P., Doan, A., Aakalu, V. K., Lanahan, A. A., Sheng, M., et al. (1999) · Neuron · doi:10.1016/s0896-6273(00)80810-7 · Cited by 1,050
Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits
Comery, T. A., Harris, J. B., Willems, P. J., Oostra, B. A., Irwin, S. A., Weiler, I. J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5401 · Cited by 1,046
Naisbitt, S., Kim, E., Tu, J. C., Xiao, B., Sala, C., Valtschanoff, J., Weinberg, R. J., Worley, P. F., & Sheng, M. (1999) · Neuron · doi:10.1016/s0896-6273(00)80809-0 · Cited by 1,009 · cited 1×
“Indeed, SHANK proteins bind to SAPAPs, which interact with PSD-95 proteins associated with glutamate receptors (102).”
BackgroundNeurexins Induce Differentiation of GABA and Glutamate Postsynaptic Specializations via Neuroligins
Graf, E. R., Zhang, X., Jin, S.-X., Linhoff, M. W., & Craig, A. M. (2004) · Cell · doi:10.1016/j.cell.2004.11.035 · Cited by 1,000
A Neuroligin-3 Mutation Implicated in Autism Increases Inhibitory Synaptic Transmission in Mice
Tabuchi, K., Blundell, J., Etherton, M. R., Hammer, R. E., Liu, X., Powell, C. M., & Südhof, T. C. (2007) · Science · doi:10.1126/science.1146221 · Cited by 997
Correction of Fragile X Syndrome in Mice
Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979
Dysregulation of the TSC-mTOR pathway in human disease
Inoki, K., Corradetti, M. N., & Guan, K.-L. (2005) · Nature Genetics · doi:10.1038/ng1494 · Cited by 972
Pten Regulates Neuronal Arborization and Social Interaction in Mice
Kwon, C.-H., Luikart, B. W., Powell, C. M., Zhou, J., Matheny, S. A., Zhang, W., Li, Y., Baker, S. J., & Parada, L. F. (2006) · Neuron · doi:10.1016/j.neuron.2006.03.023 · Cited by 970
Regulation of cap-dependent translation by eIF4E inhibitory proteins
Richter, J. D., & Sonenberg, N. (2005) · Nature · doi:10.1038/nature03205 · Cited by 970 · cited 1×
“The interaction of eIF4E with eIF4G is regulated by 4E-BPs, which repress translation by blocking the interaction of eIF4E with eIF4G (52).”
BackgroundAutistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice
Tsai, P. T., Hull, C., Chu, Y., Greene-Colozzi, E., Sadowski, A. R., Leech, J. M., Steinberg, J., Crawley, J. N., Regehr, W. G., & Sahin, M. (2012) · Nature · doi:10.1038/nature11310 · Cited by 888 · cited 1×
“Either genetic reduction or complete deletion of Tsc1 in cerebellar Purkinje cells (PCs) results in ASD-like behaviors, including impaired social interaction, altered ultrasonic vocalizations, and increased repetitive behaviors that are correlated with decreased PC excitability and changes in the number and morphology…”
BackgroundHierarchical phosphorylation of the translation inhibitor 4E-BP1
Gingras, A.-C., Raught, B., Gygi, S. P., Niedzwiecka, A., Miron, M., Burley, S. K., Polakiewicz, R. D., Wyslouch-Cieszynska, A., Aebersold, R., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.912401 · Cited by 883 · cited 1×
“Upon stimulation, 4E-BP is phosphorylated and inactivated by mTORC1, thereby enabling eIF4E to associate with eIF4G to form the eIF4F complex (53).”
BackgroundReversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis
Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., Ramesh, V., & Silva, A. J. (2008) · Nature Medicine · doi:10.1038/nm1788 · Cited by 882 · cited 1×
“However, it should be noted that specific genetic ablation of Tsc1 in either astrocytes (68) or neurons (66, 69) results in epilepsy and lethality.”
BackgroundTu, J. C., Xiao, B., Yuan, J. P., Lanahan, A. A., Leoffert, K., Li, M., Linden, D. J., & Worley, P. F. (1998) · Neuron · doi:10.1016/s0896-6273(00)80589-9 · Cited by 862 · cited 2×
“Also, SHANK proteins are involved in regulating the cytoskeleton by binding cortactin (104), inositol 1,4,5-trisphosphate (IP3) receptors, and F-actin (105, 106).”
BackgroundCortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice
Welch, J. M., Lu, J., Rodriguiz, R. M., Trotta, N. C., Peca, J., Ding, J.-D., Feliciano, C., Chen, M., Adams, J. P., Luo, J., et al. (2007) · Nature · doi:10.1038/nature06104 · Cited by 852
Neuroligins Determine Synapse Maturation and Function
Varoqueaux, F., Aramuni, G., Rawson, R. L., Mohrmann, R., Missler, M., Gottmann, K., Zhang, W., Südhof, T. C., & Brose, N. (2006) · Neuron · doi:10.1016/j.neuron.2006.09.003 · Cited by 829
Zoghbi, H. Y., & Bear, M. F. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009886 · Cited by 797
Butler, M. G., Dasouki, M. J., Zhou, X.-P., Talebizadeh, Z., Brown, M., Takahashi, T. N., Miles, J. H., Wang, C. H., Stratton, R., Pilarski, R., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.024646 · Cited by 778
Laumonnier, F., Bonnet-Brilhault, F., Gomot, M., Blanc, R., David, A., Moizard, M.-P., Raynaud, M., Ronce, N., Lemonnier, E., Calvas, P., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/382137 · Cited by 768
Regulation of Dendritic Spine Morphology and Synaptic Function by Shank and Homer
Sala, C., Piëch, V., Wilson, N. R., Passafaro, M., Liu, G., & Sheng, M. (2001) · Neuron · doi:10.1016/s0896-6273(01)00339-7 · Cited by 716 · cited 2×
“Also, SHANK proteins are involved in regulating the cytoskeleton by binding cortactin (104), inositol 1,4,5-trisphosphate (IP3) receptors, and F-actin (105, 106).”
Backgroundα-Neurexins couple Ca2+ channels to synaptic vesicle exocytosis
Missler, M., Zhang, W., Rohlmann, A., Kattenstroth, G., Hammer, R. E., Gottmann, K., & Südhof, T. C. (2003) · Nature · doi:10.1038/nature01755 · Cited by 699
Genetics of autism spectrum disorders
Geschwind, D. H. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.07.003 · Cited by 696
Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses
Song, J.-Y., Ichtchenko, K., Südhof, T. C., & Brose, N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.1100 · Cited by 696
Contribution of SHANK3 Mutations to Autism Spectrum Disorder
Moessner, R., Marshall, C. R., Sutcliffe, J. S., Skaug, J., Pinto, D., Vincent, J., Zwaigenbaum, L., Fernandez, B., Roberts, W., Szatmari, P., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/522590 · Cited by 681
Activity-dependent neuronal signalling and autism spectrum disorder
Ebert, D. H., & Greenberg, M. E. (2013) · Nature · doi:10.1038/nature11860 · Cited by 666 · cited 1×
“www Recent studies of monogenic forms of ASD have focused on at least two different clusters of genes frequently associated with ASD and intellectual disability: genes encoding for structural synaptic proteins or proteins involved in regulating protein synthesis (reviewed in (11, 15) (Figs.”
BackgroundBourgeron, T. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.06.003 · Cited by 637
SynGAP: a Synaptic RasGAP that Associates with the PSD-95/SAP90 Protein Family
Kim, J. H., Liao, D., Lau, L.-F., & Huganir, R. L. (1998) · Neuron · doi:10.1016/s0896-6273(00)81008-9 · Cited by 634
Dendritic Spine Structural Anomalies in Fragile-X Mental Retardation Syndrome
Irwin, S. A. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.10.1038 · Cited by 626
The Fragile X Syndrome Protein Represses Activity-Dependent Translation through CYFIP1, a New 4E-BP
Napoli, I., Mercaldo, V., Boyl, P. P., Eleuteri, B., Zalfa, F., De Rubeis, S., Di Marino, D., Mohr, E., Massimi, M., Falconi, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.07.031 · Cited by 609 · cited 1×
“In the initiation model, FMRP inhibits translation initiation by interacting with the eukaryotic initiation factor 4E (eIF4E)–binding protein (4E-BP)–like protein CYFIP1, which is associated with eIF4E, the cap-binding translation factor for mRNAs (27).”
BackgroundThe Autistic Neuron: Troubled Translation?
Kelleher, R. J., & Bear, M. F. (2008) · Cell · doi:10.1016/j.cell.2008.10.017 · Cited by 598 · cited 1×
“In contrast, investigations concerning the proteins that regulate translation hint at a connection between exaggerated protein synthesis and ASD phenotypes in humans and animal models (56, 57, 163).”
ResultChubykin, A. A., Atasoy, D., Etherton, M. R., Brose, N., Kavalali, E. T., Gibson, J. R., & Südhof, T. C. (2007) · Neuron · doi:10.1016/j.neuron.2007.05.029 · Cited by 594
A Synaptic Ras-GTPase Activating Protein (p135 SynGAP) Inhibited by CaM Kinase II
Chen, H.-J., Rojas-Soto, M., Oguni, A., & Kennedy, M. B. (1998) · Neuron · doi:10.1016/s0896-6273(00)80471-7 · Cited by 590
PTEN: a tumour suppressor that functions as a phospholipid phosphatase
Maehama, T. (1999) · Trends in Cell Biology · doi:10.1016/s0962-8924(99)01519-6 · Cited by 590 · cited 1×
“PTEN is a phosphatase that removes the 3′ phosphate from phosphatidylinositol 3,4,5-trisphosphate (80) and thus inhibits PI3K signaling, thereby inactivating Akt and mTORC1.”
BackgroundBozdagi, O., Sakurai, T., Papapetrou, D., Wang, X., Dickstein, D. L., Takahashi, N., Kajiwara, Y., Yang, M., Katz, A. M., Scattoni, M. L., et al. (2010) · Molecular Autism · doi:10.1186/2040-2392-1-15 · Cited by 584
Disruption of neurexin 1 associated with autism spectrum disorder
Kim, H.-G., Kishikawa, S., Higgins, A. W., Seong, I.-S., Donovan, D. J., Shen, Y., Lally, E., Weiss, L. A., Najm, J., Kutsche, K., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.09.011 · Cited by 578
Searching for ways out of the autism maze: genetic, epigenetic and environmental clues
Persico, A. M., & Bourgeron, T. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.05.010 · Cited by 575 · cited 1×
“The behavioral symptomatology of ASD encompasses a spectrum of wideranging phenotypes, which span from mild behavioral and personality traits to severe and debilitating impairments (7).”
BackgroundEvidence that fragile X mental retardation protein is a negative regulator of translation
Laggerbauer, B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.4.329 · Cited by 571
Abnormal Development of Dendritic Spines in FMR1 Knock-Out Mice
Nimchinsky, E. A., Oberlander, A. M., & Svoboda, K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05139.2001 · Cited by 560
Dysregulation of mTOR signaling in fragile X syndrome
Sharma, A., Hoeffer, C. A., Takayasu, Y., Miyawaki, T., McBride, S. M., Klann, E., & Zukin, R. S. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3696-09.2010 · Cited by 557
Self-citationJamain, S., Radyushkin, K., Hammerschmidt, K., Granon, S., Boretius, S., Varoqueaux, F., Ramanantsoa, N., Gallego, J., Ronnenberg, A., Winter, D., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711555105 · Cited by 556
Neuroligin 2 is exclusively localized to inhibitory synapses
Varoqueaux, F., Jamain, S., & Brose, N. (2004) · European Journal of Cell Biology · doi:10.1078/0171-9335-00410 · Cited by 550
Genetic architecture in autism spectrum disorder
Devlin, B., & Scherer, S. W. (2012) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2012.03.002 · Cited by 545
Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3
Wang, X., McCoy, P. A., Rodriguiz, R. M., Pan, Y., Je, H. S., Roberts, A. C., Kim, C. J., Berrios, J., Colvin, J. S., Bousquet-Moore, D., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr212 · Cited by 537
Autism-related deficits via dysregulated eIF4E-dependent translational control
Gkogkas, C. G., Khoutorsky, A., Ran, I., Rampakakis, E., Nevarko, T., Weatherill, D. B., Vasuta, C., Yee, S., Truitt, M., Dallaire, P., et al. (2013) · Nature · doi:10.1038/nature11628 · Cited by 522
Cap-Dependent Translation Initiation in Eukaryotes Is Regulated by a Molecular Mimic of eIF4G
Marcotrigiano, J., Gingras, A.-C., Sonenberg, N., & Burley, S. K. (1999) · Molecular Cell · doi:10.1016/s1097-2765(01)80003-4 · Cited by 512 · cited 1×
“The critical step in the formation of the complex is the direct association of eIF4E with eIF4G (50), an mRNA-ribosome bridging factor, and the indirect association of eIF4E with the RNA helicase eIF4A (51).”
BackgroundFeng, Y., Absher, D., Eberhart, D. E., Brown, V., Malter, H. E., & Warren, S. T. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80012-x · Cited by 510
Backman, S. A., Stambolic, V., Suzuki, A., Haight, J., Elia, A., Pretorius, J., Tsao, M.-S., Shannon, P., Bolon, B., Ivy, G. O., et al. (2001) · Nature Genetics · doi:10.1038/ng782 · Cited by 508 · cited 1×
“Overall, the effect of genetic deletion of Pten during development is dramatic, resulting in brain enlargement and gross anatomical abnormalities that are often accompanied by the development of seizures and premature death (82, 83).”
BackgroundMeikle, L., Pollizzi, K., Egnor, A., Kramvis, I., Lane, H., Sahin, M., & Kwiatkowski, D. J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0955-08.2008 · Cited by 501
Kim, M. J., Dunah, A. W., Wang, Y. T., & Sheng, M. (2005) · Neuron · doi:10.1016/j.neuron.2005.04.031 · Cited by 494 · cited 1×
“In fact, deletion of SynGAP1 in hippocampal neurons in culture has been reported to both enhance (153, 155) and suppress (154) dendritic spine formation.”
BackgroundThe translation of translational control by FMRP: therapeutic targets for FXS
Darnell, J. C., & Klann, E. (2013) · Nature Neuroscience · doi:10.1038/nn.3379 · Cited by 491 · cited 20×
“A. Orrico, L. Galli, S. Buoni, A. Orsi, G. Vonella, V. Sorrentino, Novel PTEN mutations in neurodevelopmental disorders and macrocephaly.”
BackgroundInfluentialSelf-citationRheb fills a GAP between TSC and TOR
Manning, B. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.09.003 · Cited by 483
Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease
Kwon, C.-H., Zhu, X., Zhang, J., Knoop, L. L., Tharp, R., Smeyne, R. J., Eberhart, C. G., Burger, P. C., & Baker, S. J. (2001) · Nature Genetics · doi:10.1038/ng781 · Cited by 478 · cited 1×
“Overall, the effect of genetic deletion of Pten during development is dramatic, resulting in brain enlargement and gross anatomical abnormalities that are often accompanied by the development of seizures and premature death (82, 83).”
BackgroundWaskiewicz, A. J., Johnson, J. C., Penn, B., Mahalingam, M., Kimball, S. R., & Cooper, J. A. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1871 · Cited by 469 · cited 1×
“In some experimental conditions, the phosphorylation of eIF4E is correlated with the rate of protein synthesis (54).”
BackgroundUllrich, B., Ushkaryov, Y. A., & Südhof, T. C. (1995) · Neuron · doi:10.1016/0896-6273(95)90306-2 · Cited by 468
Meikle, L., Talos, D. M., Onda, H., Pollizzi, K., Rotenberg, A., Sahin, M., Jensen, F. E., & Kwiatkowski, D. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5540-06.2007 · Cited by 462 · cited 1×
“However, it should be noted that specific genetic ablation of Tsc1 in either astrocytes (68) or neurons (66, 69) results in epilepsy and lethality.”
BackgroundBelmonte, M. K., Cook, E. H., Anderson, G. M., Rubenstein, J. L. R., Greenough, W. T., Beckel-Mitchener, A., Courchesne, E., Boulanger, L. M., Powell, S. B., Levitt, P. R., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001499 · Cited by 442
Zhou, J., Blundell, J., Ogawa, S., Kwon, C.-H., Zhang, W., Sinton, C., Powell, C. M., & Parada, L. F. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5685-08.2009 · Cited by 441 · cited 1×
“Treatment with the mTORC1 inhibitor rapamycin reverses the neuronal hypertrophy and ameliorates the seizures and social impairments (85).”
BackgroundMacrocephaly in children and adults with autism
LAINHART, J. E., PIVEN, J., WZOREK, M., LANDA, R., SANTANGELO, S. L., COON, H., & FOLSTEIN, S. E. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199702000-00019 · Cited by 439 · cited 1×
“In general, PTEN mutations are more frequent in ASD children that develop macrocephaly than in those that do not (78, 79).”
BackgroundIncidence of Fragile X Syndrome by Newborn Screening for Methylated FMR1 DNA
Coffee, B., Keith, K., Albizua, I., Malone, T., Mowrey, J., Sherman, S. L., & Warren, S. T. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.09.007 · Cited by 436 · cited 1×
“inherited intellectual disability and ASD (19, 20), occurring in about 1:5000 males and roughly half as many females.”
BackgroundBiochemical mechanisms for translational regulation in synaptic plasticity
Klann, E., & Dever, T. E. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1557 · Cited by 422 · cited 2×
“eIF4E binds to the cap structure at the 5′ terminus of mRNA and regulates the initiation step of cap-dependent translation (48, 49).”
BackgroundSelf-citationThe Pathophysiology of Fragile X Syndrome
Penagarikano, O., Mulle, J. G., & Warren, S. T. (2007) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.8.080706.092249 · Cited by 420
Common genetic variants, acting additively, are a major source of risk for autism
Klei, L., Sanders, S. J., Murtha, M. T., Hus, V., Lowe, J. K., Willsey, A. J., Moreno-De-Luca, D., Yu, T. W., Fombonne, E., Geschwind, D., et al. (2012) · Molecular Autism · doi:10.1186/2040-2392-3-9 · Cited by 418
Clement, J. P., Aceti, M., Creson, T. K., Ozkan, E. D., Shi, Y., Reish, N. J., Almonte, A. G., Miller, B. H., Wiltgen, B. J., Miller, C. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.045 · Cited by 385 · cited 1×
“Hippocampal neurons in these mice have an accelerated rate of glutamatergic synapse maturation, consequently disrupting the excitation/inhibition balance (158).”
BackgroundKomiyama, N. H., Watabe, A. M., Carlisle, H. J., Porter, K., Charlesworth, P., Monti, J., Strathdee, D. J. C., O'Carroll, C. M., Martin, S. J., Morris, R. G. M., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-22-09721.2002 · Cited by 382
Graff, J. R., Konicek, B. W., Vincent, T. M., Lynch, R. L., Monteith, D., Weir, S. N., Schwier, P., Capen, A., Goode, R. L., Dowless, M. S., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32044 · Cited by 380
Wilson, H. L., Wong, A. C. C., Shaw, S. R., Tse, W.-Y., Stapleton, G. A., Phelan, M. C., Hu, S., Marshall, J., & McDermid, H. E. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.8.575 · Cited by 377
Uhlmann, E. J., Wong, M., Baldwin, R. L., Bajenaru, M. L., Onda, H., Kwiatkowski, D. J., Yamada, K., & Gutmann, D. H. (2002) · Annals of Neurology · doi:10.1002/ana.10283 · Cited by 372 · cited 1×
“However, it should be noted that specific genetic ablation of Tsc1 in either astrocytes (68) or neurons (66, 69) results in epilepsy and lethality.”
BackgroundGauthier, J., Champagne, N., Lafrenière, R. G., Xiong, L., Spiegelman, D., Brustein, E., Lapointe, M., Peng, H., Côté, M., Noreau, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906232107 · Cited by 369
Exaggerated translation causes synaptic and behavioural aberrations associated with autism
Santini, E., Huynh, T. N., MacAskill, A. F., Carter, A. G., Pierre, P., Ruggero, D., Kaphzan, H., & Klann, E. (2013) · Nature · doi:10.1038/nature11782 · Cited by 368
Self-citationA new function for the fragile X mental retardation protein in regulation of PSD-95 mRNA stability
Zalfa, F., Eleuteri, B., Dickson, K. S., Mercaldo, V., De Rubeis, S., di Penta, A., Tabolacci, E., Chiurazzi, P., Neri, G., Grant, S. G. N., et al. (2007) · Nature Neuroscience · doi:10.1038/nn1893 · Cited by 364
Neuroligin‐3‐deficient mice: model of a monogenic heritable form of autism with an olfactory deficit
Radyushkin, K., Hammerschmidt, K., Boretius, S., Varoqueaux, F., El‐Kordi, A., Ronnenberg, A., Winter, D., Frahm, J., Fischer, J., Brose, N., et al. (2009) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2009.00487.x · Cited by 358
Hung, A. Y., Futai, K., Sala, C., Valtschanoff, J. G., Ryu, J., Woodworth, M. A., Kidd, F. L., Sung, C. C., Miyakawa, T., Bear, M. F., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3032-07.2008 · Cited by 350
Mutations in SYNGAP1 in Autosomal Nonsyndromic Mental Retardation
Hamdan, F. F., Gauthier, J., Spiegelman, D., Noreau, A., Yang, Y., Pellerin, S., Dobrzeniecka, S., Côté, M., Perreau-Linck, E., Carmant, L., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805392 · Cited by 336 · cited 1×
“SYNGAP1 Deletion of SYNGAP1 or a mutation introducing a premature stop codon in SYNGAP1 is found in a few patients with intellectual disability with or without ASD (121, 142).”
BackgroundTuberous sclerosis: a GAP at the crossroads of multiple signaling pathways
Kwiatkowski, D. J., & Manning, B. D. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi260 · Cited by 332 · cited 1×
“Therefore, in the absence of either TSC1 or TSC2, high amounts of Rheb-GTP lead to constitutive activation of mTORC1 signaling, thereby resulting in dysregulated protein synthesis and cell growth (64).”
BackgroundPhosphorylation influences the translation state of FMRP-associated polyribosomes
Ceman, S., O'Donnell, W. T., Reed, M., Patton, S., Pohl, J., & Warren, S. T. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg350 · Cited by 327
Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients
Yan, J., Oliveira, G., Coutinho, A., Yang, C., Feng, J., Katz, C., Sram, J., Bockholt, A., Jones, I. R., Craddock, N., et al. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001629 · Cited by 324
Novel de novo SHANK3 mutation in autistic patients
Gauthier, J., Spiegelman, D., Piton, A., Lafrenière, R. G., Laurent, S., St‐Onge, J., Lapointe, L., Hamdan, F. F., Cossette, P., Mottron, L., et al. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30822 · Cited by 321
Structure and Evolution of Neurexin Genes: Insight into the Mechanism of Alternative Splicing
Tabuchi, K., & Südhof, T. C. (2002) · Genomics · doi:10.1006/geno.2002.6780 · Cited by 305
Characterization of the Shank Family of Synaptic Proteins
Lim, S., Naisbitt, S., Yoon, J., Hwang, J.-I., Suh, P.-G., Sheng, M., & Kim, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29510 · Cited by 295
Promoter-Bound Trinucleotide Repeat mRNA Drives Epigenetic Silencing in Fragile X Syndrome
Colak, D., Zaninovic, N., Cohen, M. S., Rosenwaks, Z., Yang, W.-Y., Gerhardt, J., Disney, M. D., & Jaffrey, S. R. (2014) · Science · doi:10.1126/science.1245831 · Cited by 294
eIF4E activity is regulated at multiple levels
Raught, B., & Gingras, A.-C. (1999) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00131-9 · Cited by 290 · cited 1×
“The critical step in the formation of the complex is the direct association of eIF4E with eIF4G (50), an mRNA-ribosome bridging factor, and the indirect association of eIF4E with the RNA helicase eIF4A (51).”
BackgroundKrapivinsky, G., Medina, I., Krapivinsky, L., Gapon, S., & Clapham, D. E. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.003 · Cited by 287 · cited 1×
“In fact, deletion of SynGAP1 in hippocampal neurons in culture has been reported to both enhance (153, 155) and suppress (154) dendritic spine formation.”
BackgroundPhelan, M. C., Rogers, R. C., Saul, R. A., Stapleton, G. A., Sweet, K., McDermid, H., Shaw, S. R., Claytor, J., Willis, J., & Kelly, D. P. (2001) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20010615)101:2<91::aid-ajmg1340>3.0.co;2-c · Cited by 279
Fragile X mental retardation protein is associated with translating polyribosomes in neuronal cells
Stefani, G., Fraser, C. E., Darnell, J. C., & Darnell, R. B. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.2306-04.2004 · Cited by 274
High frequency of neurexin 1β signal peptide structural variants in patients with autism
Feng, J., Schroer, R., Yan, J., Song, W., Yang, C., Bockholt, A., Cook, E. H., Skinner, C., Schwartz, C. E., & Sommer, S. S. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.08.017 · Cited by 270
Familial deletion within NLGN4 associated with autism and Tourette syndrome
Lawson-Yuen, A., Saldivar, J.-S., Sommer, S., & Picker, J. (2008) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5202006 · Cited by 269
Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly
Buxbaum, J. D., Cai, G., Chaste, P., Nygren, G., Goldsmith, J., Reichert, J., Anckarsäter, H., Rastam, M., Smith, C. J., Silverman, J. M., et al. (2007) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30493 · Cited by 269
A Genomewide Screen of 345 Families for Autism-Susceptibility Loci
Yonan, A. L., Alarcón, M., Cheng, R., Magnusson, P. K. E., Spence, S. J., Palmer, A. A., Grunn, A., Hank Juo, S.-H., Terwilliger, J. D., Liu, J., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/378778 · Cited by 268 · cited 1×
“Genetic variants in chromosome 4q, which contains the EIF4E locus, have been described in patients with ASD (44, 45).”
BackgroundQin, M., Kang, J., Burlin, T. V., Jiang, C., & Smith, C. B. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0093-05.2005 · Cited by 263 · cited 3×
“Genetic deletion of Homer1a restores the normal mGluR5-Homer association and corrects several phe- www notypes in Fmr1 null mice, including enhanced global protein synthesis (161, 162).”
BackgroundMethodSynGAP regulates synaptic strength and mitogen-activated protein kinases in cultured neurons
Rumbaugh, G., Adams, J. P., Kim, J. H., & Huganir, R. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600084103 · Cited by 260
Autism and Associated Medical Disorders in a French Epidemiological Survey
FOMBONNE, E., DU MAZAUBRUN, C., CANS, C., & GRANDJEAN, H. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/s0890-8567(09)66566-7 · Cited by 259 · cited 13×
“Moreover, several mRNA targets of FMRP encode repressors of the mTORC1 signaling pathway, including tuberin (TSC2) and phosphatase and tensin homolog (PTEN) (34).”
BackgroundInfluentialBoeckers, T. M., Kreutz, M. R., Winter, C., Zuschratter, W., Smalla, K.-H., Sanmarti-Vila, L., Wex, H., Langnaese, K., Bockmann, J., Garner, C. C., et al. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-15-06506.1999 · Cited by 257
Du, Y., Weed, S. A., Xiong, W.-C., Marshall, T. D., & Parsons, J. T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.10.5838 · Cited by 254
The fragile X mental retardation protein is associated with ribosomes
Khandjian, E. W., Corbin, F., Woerly, S., & Rousseau, F. (1996) · Nature Genetics · doi:10.1038/ng0196-91 · Cited by 251
Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome
Ronesi, J. A., Collins, K. A., Hays, S. A., Tsai, N.-P., Guo, W., Birnbaum, S. G., Hu, J.-H., Worley, P. F., Gibson, J. R., & Huber, K. M. (2012) · Nature Neuroscience · doi:10.1038/nn.3033 · Cited by 251
Tsc2-Rheb signaling regulates EphA-mediated axon guidance
Nie, D., Di Nardo, A., Han, J. M., Baharanyi, H., Kramvis, I., Huynh, T., Dabora, S., Codeluppi, S., Pandolfi, P. P., Pasquale, E. B., et al. (2010) · Nature Neuroscience · doi:10.1038/nn.2477 · Cited by 248
Banko, J. L., Hou, L., Poulin, F., Sonenberg, N., & Klann, E. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5196-05.2006 · Cited by 245 · cited 1×
“Thus, eIF4E and cap-dependent protein synthesis can be regulated by both mTORC1 and ERK signaling (55) (Figs.”
BackgroundSelf-citationGross, C., Nakamoto, M., Yao, X., Chan, C.-B., Yim, S. Y., Ye, K., Warren, S. T., & Bassell, G. J. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0402-10.2010 · Cited by 241 · cited 1×
“Increased signaling by the mammalian target of rapamycin complex 1 (mTORC1) is seen in Fmr1 null mice (37) that likely is induced by the increased abundance of the GTPase PIKE, which connects the activation of metabotropic glutamate receptor 5 (mGluR5) to the phosphatidylinositol 3-kinase (PI3K)–mTORC1 signaling pathw…”
BackgroundThe role of synaptic GTPase-activating protein in neuronal development and synaptic plasticity
Kim, J. H., Lee, H.-K., Takamiya, K., & Huganir, R. L. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01119.2003 · Cited by 240
Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders
Boccuto, L., Lauri, M., Sarasua, S. M., Skinner, C. D., Buccella, D., Dwivedi, A., Orteschi, D., Collins, J. S., Zollino, M., Visconti, P., et al. (2013) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.175 · Cited by 240
Persico, A. M., & Napolioni, V. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.06.012 · Cited by 238
Ontogeny of postsynaptic density proteins at glutamatergic synapses
Petralia, R. S., Sans, N., Wang, Y.-X., & Wenthold, R. J. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.03.013 · Cited by 236
Levitt, P., & Campbell, D. B. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37934 · Cited by 234
Cognitive deficits in Tsc1+/−mice in the absence of cerebral lesions and seizures
Goorden, S. M. I., van Woerden, G. M., van der Weerd, L., Cheadle, J. P., & Elgersma, Y. (2007) · Annals of Neurology · doi:10.1002/ana.21317 · Cited by 230
Phelan, M. C. (2008) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-3-14 · Cited by 221
Wöhr, M., Roullet, F. I., Hung, A. Y., Sheng, M., & Crawley, J. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020631 · Cited by 220 · cited 1×
“Genetic deletion of Shank1 results in abnormal grooming behavior and impairments in ultrasonic vocalization, but normal social interactions (110, 111), contextual fear, and long-term spatial memory (112).”
BackgroundSociability and motor functions in Shank1 mutant mice
Silverman, J. L., Turner, S. M., Barkan, C. L., Tolu, S. S., Saxena, R., Hung, A. Y., Sheng, M., & Crawley, J. N. (2011) · Brain Research · doi:10.1016/j.brainres.2010.09.026 · Cited by 218 · cited 1×
“Genetic deletion of Shank1 results in abnormal grooming behavior and impairments in ultrasonic vocalization, but normal social interactions (110, 111), contextual fear, and long-term spatial memory (112).”
BackgroundSapap3 and pathological grooming in humans: Results from the OCD collaborative genetics study
Bienvenu, O. J., Wang, Y., Shugart, Y. Y., Welch, J. M., Grados, M. A., Fyer, A. J., Rauch, S. L., McCracken, J. T., Rasmussen, S. A., Murphy, D. L., et al. (2009) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30897 · Cited by 207
Kielinen, M., Rantala, H., Timonen, E., Linna, S.-L., & Moilanen, I. (2004) · Autism · doi:10.1177/1362361304040638 · Cited by 199 · cited 13×
“Moreover, several mRNA targets of FMRP encode repressors of the mTORC1 signaling pathway, including tuberin (TSC2) and phosphatase and tensin homolog (PTEN) (34).”
BackgroundInfluentialMultiple rare SAPAP3 missense variants in trichotillomania and OCD
Züchner, S., Wendland, J. R., Ashley-Koch, A. E., Collins, A. L., Tran-Viet, K. N., Quinn, K., Timpano, K. C., Cuccaro, M. L., Pericak-Vance, M. A., Steffens, D. C., et al. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.83 · Cited by 196
PTEN signaling in autism spectrum disorders
Zhou, J., & Parada, L. F. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2012.05.004 · Cited by 188 · cited 2×
“Given the importance of PI3K-Akt-mTORC1 signaling in the control of cell growth, survival, and proliferation, it is not surprising that PTEN inactivation leads to human cancers and neurological disorders (81).”
BackgroundDendritic spine abnormalities in the occipital cortex of C57BL/6Fmr1 knockout mice
McKinney, B. C., Grossman, A. W., Elisseou, N. M., & Greenough, W. T. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30183 · Cited by 184
Neurexin 1α structural variants associated with autism
Jin, Y., Noltner, K., Feng, J., Li, W., Schroer, R. J., Skinner, C. D., Zeng, W., Schwartz, C. E., & Sommer, S. S. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.04.074 · Cited by 183
Autistic phenotypes and genetic testing: state-of-the-art for the clinical geneticist
Lintas, C., & Persico, A. M. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.060871 · Cited by 178
Fragile X: Leading the Way for Targeted Treatments in Autism
Wang, L. W., Berry-Kravis, E., & Hagerman, R. J. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.005 · Cited by 176 · cited 1×
“inherited intellectual disability and ASD (19, 20), occurring in about 1:5000 males and roughly half as many females.”
BackgroundNovel splice isoforms for NLGN3 and NLGN4 with possible implications in autism
Talebizadeh, Z., Lam, D. Y., Theodoro, M. F., Bittel, D. C., Lushington, G. H., & Butler, M. G. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.036897 · Cited by 172
Abnormal Striatal GABA Transmission in the Mouse Model for the Fragile X Syndrome
Centonze, D., Rossi, S., Mercaldo, V., Napoli, I., Ciotti, M. T., De Chiara, V., Musella, A., Prosperetti, C., Calabresi, P., Bernardi, G., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.09.008 · Cited by 171
Macrocephaly in autism and other pervasive developmental disorders
Fidler, D. J., Bailey, J. N., & Smalley, S. L. (2000) · Developmental Medicine & Child Neurology · doi:10.1017/s0012162200001365 · Cited by 169 · cited 1×
“In general, PTEN mutations are more frequent in ASD children that develop macrocephaly than in those that do not (78, 79).”
BackgroundSchütt, J., Falley, K., Richter, D., Kreienkamp, H.-J., & Kindler, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.042663 · Cited by 155 · cited 6×
“Similar to SAPAP3, genetic ablation of SAPAP2 (DLGAP2) in mice increases aggressive behavior and results in impaired social interactions.”
BackgroundInfluentialPage, D. T., Kuti, O. J., Prestia, C., & Sur, M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804428106 · Cited by 149
Silencing of Neuroligin Function by Postsynaptic Neurexins
Taniguchi, H., Gollan, L., Scholl, F. G., Mahadomrongkul, V., Dobler, E., Limthong, N., Peck, M., Aoki, C., & Scheiffele, P. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0032-07.2007 · Cited by 143
Deregulation of EIF4E: a novel mechanism for autism
Neves-Pereira, M., Müller, B., Massie, D., Williams, J. H. G., O’Brien, P. C. M., Hughes, A., Shen, S.-B., Clair, D. S., & Miedzybrodzka, Z. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.066852 · Cited by 142
Giuffrida, R., Musumeci, S., D'Antoni, S., Bonaccorso, C. M., Giuffrida-Stella, A. M., Oostra, B. A., & Catania, M. V. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0932-05.2005 · Cited by 141 · cited 3×
“Genetic deletion of Homer1a restores the normal mGluR5-Homer association and corrects several phe- www notypes in Fmr1 null mice, including enhanced global protein synthesis (161, 162).”
Background22q13.3 deletion syndrome: clinical and molecular analysis using array CGH
Dhar, S. U., del Gaudio, D., German, J. R., Peters, S. U., Ou, Z., Bader, P. I., Berg, J. S., Blazo, M., Brown, C. W., Graham, B. H., et al. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33253 · Cited by 138
FMRP is associated to the ribosomes via RNA
Tamanini, F. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.6.809 · Cited by 137
Genetic and acute CPEB1 depletion ameliorate fragile X pathophysiology
Udagawa, T., Farny, N. G., Jakovcevski, M., Kaphzan, H., Alarcon, J. M., Anilkumar, S., Ivshina, M., Hurt, J. A., Nagaoka, K., Nalavadi, V. C., et al. (2013) · Nature Medicine · doi:10.1038/nm.3353 · Cited by 135 · cited 16×
“FMRP is an RNA-binding protein that is involved in many aspects of the posttranscriptional regulation of mRNA, such as stability, dendritic transport, and translational control.”
BackgroundInfluentialSelf-citationA patient with vertebral, cognitive and behavioural abnormalities and a de novo deletion of NRXN1α
Zahir, F. R., Baross, A., Delaney, A. D., Eydoux, P., Fernandes, N. D., Pugh, T., Marra, M. A., & Friedman, J. M. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2007.054437 · Cited by 132
Clipperton-Allen, A. E., & Page, D. T. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu057 · Cited by 132 · cited 1×
“Moreover, mice with germline Pten haploinsufficiency (Pten) exhibit increased total brain mass and ASD-like behavioral impairments, such as abnormal social behavior and sensorimotor gating (86), increased repetitive behaviors, and depressive-like behaviors (87).”
BackgroundJansen, L. A., Uhlmann, E. J., Crino, P. B., Gutmann, D. H., & Wong, M. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.00289.x · Cited by 129
Ehninger, D., De Vries, P. J., & Silva, A. J. (2009) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2009.01208.x · Cited by 120 · cited 1×
“However, inhibition of de novo protein synthesis impairs long-lasting plasticity and cognition [reviewed in (48, 164)] and likely contributes to cognitive deficits in TSC model mice (165).”
BackgroundSantini, E., Huynh, T. N., & Klann, E. (2014) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-420170-5.00005-2 · Cited by 118 · cited 1×
“However, inhibition of de novo protein synthesis impairs long-lasting plasticity and cognition [reviewed in (48, 164)] and likely contributes to cognitive deficits in TSC model mice (165).”
BackgroundSelf-citationWelch, J. M., Wang, D., & Feng, G. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20060 · Cited by 115 · cited 2×
“The members of the SAPAP family, also referred to as guanylate kinase– associated proteins (GKAPs), are postsynaptic scaffold proteins that are localized to the PSD uniquely at excitatory synapses (147).”
BackgroundTing, J. T., Peça, J., & Feng, G. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062111-150442 · Cited by 108 · cited 1×
“Therefore, in the current model of PSD organization, PSD-95SAPAP-SHANK interactions play an important role in the constitution of the large postsynaptic signaling complex at glutamatergic synapses (148).”
BackgroundNovel PTEN mutations in neurodevelopmental disorders and macrocephaly
Orrico, A., Galli, L., Buoni, S., Orsi, A., Vonella, G., & Sorrentino, V (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2008.01074.x · Cited by 105
The Clinical Assessment of Attachment in Children Under Five
Boris, N. W., Fueyo, M., & Zeanah, C. H. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199702000-00020 · Cited by 105
FISH-mapping of a 100-kb terminal 22q13 deletion
Anderlid, B., Schoumans, J., Annerén, G., Tapia‐Páez, I., Dumanski, J. P., Blennow, E., & Nordenskjöld, M. (2002) · Human Genetics · doi:10.1007/s00439-002-0713-7 · Cited by 93
Jiang-Xie, L.-F., Liao, H.-M., Chen, C.-H., Chen, Y.-T., Ho, S.-Y., Lu, D.-H., Lee, L.-J., Liou, H.-H., Fu, W.-M., & Gau, S. S.-F. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-32 · Cited by 79
Boardman, L., van der Merwe, L., Lochner, C., Kinnear, C., Seedat, S., Stein, D., Moolman-Smook, J., & Hemmings, S. (2011) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2010.05.007 · Cited by 78
Daoud, H., Bonnet‐Brilhault, F., Védrine, S., Demattei, M.-V., Vourc’h, P., Bayou, N., Andres, C. R., Barthélémy, C., Laumonnier, F., & Briault, S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.05.008 · Cited by 75 · cited 1×
“This mutation causes increased activity of promoter and, subsequently, increased NLGN4 expression (126), curiously suggesting that increased or decreased abundance of neuroligin-4 may be similarly detrimental to neuronal function and result in ASD-like phenotypes.”
BackgroundConti, S., Condò, M., Posar, A., Mari, F., Resta, N., Renieri, A., Neri, I., Patrizi, A., & Parmeggiani, A. (2012) · Journal of Child Neurology · doi:10.1177/0883073811420296 · Cited by 75
The fragile X mental retardation protein has nucleic acid chaperone properties
Gabus, C. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh535 · Cited by 74
Chocholska, S., Rossier, E., Barbi, G., & Kehrer‐Sawatzki, H. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31145 · Cited by 73
Family‐based genetic association study of DLGAP3 in Tourette Syndrome
Crane, J., Fagerness, J., Osiecki, L., Gunnell, B., Stewart, S. E., Pauls, D. L., Scharf, J. M., & the Tourette Syndrome International Consortium for Genetics (TSAICG) (2011) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31134 · Cited by 71
Deletions of VCX‐A and NLGN4: a variable phenotype including normal intellect
Macarov, M., Zeigler, M., Newman, J. P., Strich, D., Sury, V., Tennenbaum, A., & Meiner, V. (2007) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2006.00880.x · Cited by 70
Lacoux, C., Di Marino, D., Pilo Boyl, P., Zalfa, F., Yan, B., Ciotti, M. T., Falconi, M., Urlaub, H., Achsel, T., Mougin, A., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1254 · Cited by 67
Autism-epilepsy phenotype with macrocephaly suggests PTEN, but not GLIALCAM, genetic screening
Marchese, M., Conti, V., Valvo, G., Moro, F., Muratori, F., Tancredi, R., Santorelli, F. M., Guerrini, R., & Sicca, F. (2014) · BMC Medical Genetics · doi:10.1186/1471-2350-15-26 · Cited by 62
Waga, C., Okamoto, N., Ondo, Y., Fukumura-Kato, R., Goto, Y.-I., Kohsaka, S., & Uchino, S. (2011) · Psychiatric Genetics · doi:10.1097/ypg.0b013e328341e069 · Cited by 57
Curatolo, P., & Bombardieri, R. (2007) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)87009-6 · Cited by 57
Deep exon resequencing of DLGAP2 as a candidate gene of autism spectrum disorders
Chien, W.-H., Gau, S.-F., Liao, H.-M., Chiu, Y.-N., Wu, Y.-Y., Huang, Y.-S., Tsai, W.-C., Tsai, H.-M., & Chen, C.-H. (2013) · Molecular Autism · doi:10.1186/2040-2392-4-26 · Cited by 55
Common EIF4E variants modulate risk for autism spectrum disorders in the high-functioning range
Waltes, R., Gfesser, J., Haslinger, D., Schneider-Momm, K., Biscaldi, M., Voran, A., Freitag, C. M., & Chiocchetti, A. G. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1230-2 · Cited by 27 · cited 1×
“Notably, in ASD subjects, several of these common genetic variants in the EIF4E gene are associated with a clinical phenotype characterized by repetitive and stereotyped behaviors, but not intellectual disability (46).”
BackgroundApproach to the Genetic Evaluation of the Child with Autism
Toriello, H. V. (2012) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2011.10.014 · Cited by 26
Measurements of TSC2 GAP Activity Toward Rheb
Li, Y., Inoki, K., Vikis, H. G., & Guan, K. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)07005-9 · Cited by 18 · cited 1×
“The impact of the different mutations on clinical phenotypes is extremely variable with respect to symptoms and disease severity, and in part is dependent on which TSC gene is affected (60).”
Background
Cited by
Maternal immune activation: Implications for neuropsychiatric disorders
Estes, M. L., & McAllister, A. K. (2016) · Science · doi:10.1126/science.aag3194 · Cited by 1,206
Immune mediators in the brain and peripheral tissues in autism spectrum disorder
Estes, M. L., & McAllister, A. K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3978 · Cited by 514
Lessons learned from studying syndromic autism spectrum disorders
Sztainberg, Y., & Zoghbi, H. Y. (2016) · Nature Neuroscience · doi:10.1038/nn.4420 · Cited by 281
Lombardo, M. V., Moon, H. M., Su, J., Palmer, T. D., Courchesne, E., & Pramparo, T. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.15 · Cited by 201
“78,79 Key to this mechanism is the aberrant regulation of the PI3K–TSC1/2–mTOR signaling pathways, which in turn are responsible for the regulation of ribosomal protein S6 kinase (RPS6K) and EIF4E-binding partners (EIF4EBP1/2), acting to promote translation initiation.”
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons
Zaslavsky, K., Zhang, W.-B., McCready, F. P., Rodrigues, D. C., Deneault, E., Loo, C., Zhao, M., Ross, P. J., El Hajjar, J., Romm, A., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0365-8 · Cited by 174
Metadata
- Authors
- Santini, E., & Klann, E.
- Affiliations
- New York University (US)
- Corresponding author
- Klann, Eric
- Venue
- Science Signaling
- Published
- 2014-10-28
- Volume
- 7
- Issue
- 349
- Pages
- re10-re10
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- PMC
- PMC6002803
- OpenAlex
- W2022415974
- Cited by
- 118
- References
- 170
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 5 · 2023: 13 · 2022: 8 · 2021: 10 · 2020: 13 · 2019: 8 · 2018: 5 · 2017: 19 · 2016: 8 · 2015: 8 · 2014: 1
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science Signaling (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS-047384, NS-034007, NS087112, R01NS047384)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- autism spectrum disorder, translational regulation, synaptic function, mRNA translation, genetic mutations, signaling pathways, mouse model, intellectual disability, neurodevelopmental disorders
- MeSH terms
- SAP90-PSD95 Associated Proteins, Tuberous Sclerosis Complex 1 Protein, Tuberous Sclerosis Complex 2 Protein, Animals, Child Development Disorders, Pervasive, Humans, Models, Biological, Nerve Tissue Proteins, Synapses, Protein Biosynthesis, Signal Transduction, ras GTPase-Activating Proteins, Tumor Suppressor Proteins, Eukaryotic Initiation Factor-4E, PTEN Phosphohydrolase, Mice, Fragile X Mental Retardation Protein, Fragile X Messenger Ribonucleoprotein 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.